Coronary heart disease (CHD) mortality rates have declined for the past 25 years in most western countries. During the 1970s and early 1980s, a decline in incidence was the main factor in the decline in mortality, but more recently, improvements in treatment and prognosis have played a larger role. Most of the change is a result of improvements in the treatment of risk factors among patients with chronic CHD, while the treatment of acute myocardial infarction has contributed a smaller part. CHD mortality has consistently decreased more than incidence, which may have led to an increased prevalence of CHD. Simultaneously, the treatment practice patterns and possibly also clinical presentation of CHD has changed so that hospitalizations as a result of CHD diagnoses other than myocardial infarction have increased, while definite myocardial infarctions have decreased. Furthermore, the stabilizing rates of incident myocardial infarction combined with the aging population tend to increase the numbers of CHD patients. Therefore, the total burden of CHD to the community has decreased less than one would expect on the basis of age-standardized mortality rates. There is a need to re-emphasize primary prevention, since heavy reliance on expensive treatments for the post-war baby-boom generation presents a major concern for public health resources.
UemuraKPisaZ. Trends in cardiovascular disease mortality in industrialized countries since 1950. World Health Stat Q1988; 41: 155–178.
2.
FeinleibM. Trends in heart disease in the United States. Am J Med Sci1995; 310 (suppl 1): S8–S14.
3.
HavlikRJFeinleibM (editors). Proceedings of the conference on the Decline in Coronary Heart Disease Mortality. Bethesda, MD: National Institutes of Health, May 1979. (National Institutes of Health Publication no 79–1610.)
4.
BeagleholeR. International trends in coronary heart disease mortality, morbidity, and risk factors. Epidemiol Rev1990; 12: 1–14.
5.
HuninkMGoldmanLTostesonAMittlemanRGoldmanPWilliamsRThe recent decline in mortality from coronary heart disease, 1980–1990: The effect of secular trends in risk factors and treatment. JAMA1997; 277: 535–542.
6.
Statistically sophisticated analysis of computer-simulation state-transition models, which suggest that approximately a quarter of the decline in CHD mortality during the 1980s can be explained by primary prevention and over 70% explained by secondary reduction in risk factors or improvements in treatment of patients with CHD.
7.
Tunstall-Pedoe H, on behalf of the WHO MONICA Project. The World Health Organization MONICA Project (Monitoring Trends and Determinants in Cardiovascular Disease): a major international collaboration. J Clin Epidemiol1988; 41: 105–114.
8.
The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol1989; 129: 687–702.
9.
Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet1994; 344: 1383–1389.
10.
A landmark study, which convincingly showed the effect of cholesterol lowering in patients with CHD.
11.
SacksFMPfefferMAMoyeLARouleauJLRuthefordJDColeTGThe effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med1996; 335: 1001–1009.
12.
This study showed that the benefits of cholesterol lowering in CHD patients extend to persons with average cholesterol levels.
13.
SansSKestelootH, Kromhout D and the Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. The burden of cardiovascular diseases mortality in Europe. Eur Heart J1997; 18: 1231–1248.
14.
A major document on cardiovascular mortality and morbidity statistics in Europe, also including information from eastern Europe and from smaller areas within each country.
15.
American Heart Association. 1998 Heart and Stroke Statistical Update. Dallas, Texas: American Heart Association; 1997.
16.
VartiainenEPuskaPPekkanenJTuomilehtoJJousilahtiP. Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland. BMJ1994; 309: 23–27.
17.
An interesting analysis based on a long series of standardized risk factor surveys and mortality statistics in the same population.
18.
SytkowskiPAKannelWBD'AgostinoRA. Changes in risk factors and the decline in mortality from cardiovascular disease. N Engl J Med1990; 322: 1635–1641.
19.
This paper from the Framingham Study presents data on changes in the prevalence and incidence of CHD, which are not easily available elsewhere.
20.
SigfussonNSigvaldasonHSteingrimsdottirLGudmundsdottirIIStefansdottirIThorsteinssonTSigurdssonG. Decline in ischaemic heart disease in Iceland and change in risk factor levels. BMJ1991; 302: 1371–1375.
21.
WilhelmsenL. Cardiovascular monitoring of a city over 50 years. Eur Heart J1997; 18: 1220–1230.
22.
A valuable report based on long experience in monitoring of the occurrence of cardiovascular diseases and their risk factors in the city of Gothenburg, Sweden.
23.
McGovernPGPankowJSShaharEDoliznyKMFolsomARBlackburnHLuepkerRV. Recent trends in acute coronary heart disease - mortality, morbidity, medical care, and risk factors. N Engl J Med1996; 334: 884–890.
24.
This paper demonstrates improved short-term and long-term prognosis of myocardial infarction patients in Minnesota and suggests that medical care had a stronger effect than primary prevention in the late 1980s.
25.
BotsMLGrobbeeDE. Decline of coronary heart disease mortality in the Netherlands from 1978 to 1985: contribution of medical care and changes over time in presence of major cardiovascular risk factors. J Cardiovasc Risk1996; 3: 271–276.
26.
FrostPHDavisBRBurlandoAJCurbJDGurthrieGPIsaacsohnJLCoronary heart disease risk factors in men and women aged 60 years and older: findings from the Systolic Hypertension in the Elderly Program. Circulation1996; 94: 26–34.
27.
TervahautaMPekkanenJNissinenA. Risk factors of coronary heart disease and total mortality among elderly men with and without preexisting coronary heart disease. Finish cohorts of the Seven Countries Study. J Am Coll Cardiol1995; 26: 1623–1629.
28.
Despite its small size this prospective study succeeds in showing the effect of risk factors in elderly men with CHD.
29.
SalomaaVMiettinenHKuulasmaaKNiemelaMKetonenMVuorenmaaTDecline of coronary heart disease mortality in Finland during 1983 to 1992: roles of incidence, recurrence and case-fatality. The FINMONICA MI Register Study. Circulation1996; 94: 3130–3137.
30.
This paper shows that that the decreased occurrence of recurrent coronary events has played a prominent role in the decline of CHD mortality suggesting a substantial effect of secondary prevention measures and treatment of chronic, symptomatic CHD.
31.
WilhelmsenLRosengrenAJohanssonSLappasG. Coronary heart disease attack rate, incidence and mortality 1975–1994 in Göteborg, Sweden. Eur Heart J1997; 18: 572–581.
32.
This report is based on a long period of data collection using standardized methods and gives a good perspective over a long time.
33.
OslerMSørensenTIASørensenSRostgaardKJensenGIversenLTrends in mortality, incidence and case-fatality of ischaemic heart disease in Denmark, 1982–1992. Int J Epidemiol1996; 25: 1154–1161.
34.
RosamondWDChamblessLEFolsomARCooperLSConwillDCleggLTrends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med1998; 339: 861–867.
35.
This is the most recent paper from a major study in the USA. It presents trend data on CHD mortality, myocardial infarction incidence, recurrence, and case fatality for four USA communities. Trends among USA blacks and whites are provided.
36.
DeStefanoFMerrittRAndaRCasperMEakerE. Trends in nonfatal coronary heart disease in the United States, 1980 through 1989. Arch Intern Med1993; 153: 2489–2494.
37.
Marques-VidalPFerrièresJMetzgerM-HCambouJ-PFilipiakBLöwelHKeilU. Trends in coronary heart disease morbidity and mortality and acute coronary care and case fatality from 1985–1989 in southern Germany and south-western France. Results from the MONICA Projects in Augsburg and Toulouse. Eur Heart J1997; 18: 816–821.
38.
TavazziLVolpiA. Remarks about postinfarction prognosis in light of the experience with the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI) Trials. Circulation1997; 95: 1341–1345.
39.
FerrièresJCambouJ-PRuidavetsJ-PPousJ. Trends in acute myocardial infarction prognosis and treatment in southwestern France between 1985 and 1990. The MONICA Project-Toulouse. Am J Cardiol1995; 75: 1202–1205.
40.
An interesting article on case fatality trends from an area where the use of modern treatments has been very active.
41.
HopperJLPathikBHuntDChanWWC. Improved prognosis of myocardial infarction treated in a coronary care unit: lack of relation with changes in severity. BMJ1989; 299: 892–896.
42.
Salomaa V, Miettinen H, Palomäki P, Arstila M, Mustaniemi H, Kuulasmaa K, Tuomilehto J, for the FINMONICA AMI Register Study Group. Diagnostic features of acute myocardial infarction - changes over time from 1983 to 1990: results from the FINMONICA AMI register study. J Intern Med1995; 237: 151–159.
43.
BataIREastwoodBJGregorRDGuernseyJRKlassenGAMacKenzieBRWolfHK. Decreasing mortality from acute myocardial infarctions: effect of attack rates and case severity. J Clin Epidemiol1997; 50: 787–791.
44.
BurkeGLEdlavitchSACrowRS. The effects of diagnostic criteria on trends in coronary heart disease morbidity: The Minnesota Heart Survey. J Clin Epidemiol1989; 42: 17–24.
45.
BonneuxLLoomanCWNBarendregtJJVan der MaasPJ. Regression analysis of recent changes in cardiovascular morbidity and mortality in the Netherlands. BMJ1997; 314: 789–792.
46.
A fascinating application of vital statistics and hospital discharge register data to give a picture on CHD mortality and morbidity trends in the whole population of The Netherlands.
